Noemi Malandrino, M.D., Ph.D.
Professional Experience
- Assistant Research Physician, Section on Pediatric Diabetes, Obesity & Metabolism, NIDDK, NIH, 2024-Present
- Staff Clinician, Section on Pediatric Diabetes, Obesity & Metabolism, NIDDK, NIH, 2024-Present
- Research Collaborator, Section on Pediatric Diabetes, Obesity & Metabolism, NIDDK, NIH, 2023-2024
- Adult Endocrinology, Diabetes and Metabolism Fellowship (ABIM Research Pathway), Division of Endocrinology, Johns Hopkins School of Medicine, 2020-2024
- Internal Medicine Residency, University of Maryland Medical Center, Midtown Campus, 2018-2020
- Postdoctoral Fellowship, Section on Translational Diabetes and Metabolic Syndromes, NIDDK, NIH, 2016-2018
- Ph.D., Catholic University of Rome, Department of Internal Medicine, Italy, 2013-2016
- Postdoctoral Fellowship, Brown University Medical School, Department of Medicine, Division of Endocrinology, 2009-2011
- Internal Medicine Residency, Catholic University of Rome, Department of Internal Medicine, Italy, 2007-2012
- M.D., Catholic University of Rome, Italy, 2005
Current Research
The focus of our research is to study the natural history and pathogenesis of obesity, type 2 diabetes and related cardiometabolic disease across the lifespan, as well as investigating factors affecting treatment response in metabolic disease. The ultimate goal is to develop novel personalized strategies for prevention and treatment of metabolic disease, type 2 diabetes and their complications.
Select Publications
- Body Mass Index and Diabetes Incidence Across the Adult Lifespan: The Baltimore Longitudinal Study of Aging.
- Malandrino N, Metter EJ, Simonsick EM, Egan JM, Chia CW, Walston JD, Ferrucci L, Kalyani RR.
- J Endocr Soc (2024 Sep 26) 8:bvae156. Abstract/Full Text
- Obesity and Aging.
- Malandrino N, Bhat SZ, Alfaraidhy M, Grewal RS, Kalyani RR.
- Endocrinol Metab Clin North Am (2023 Jun) 52:317-339. Abstract/Full Text
Research in Plain Language
Our research aims to understand how youth and adults develop obesity and type 2 diabetes, and how these diseases can lead to cardiovascular and metabolic complications. We also study how lifestyle changes and medications can help prevent and improve metabolic disease.